The Ultra-Long Study: A Randomized Controlled Trial Evaluating Long-Term GnRH Downregulation Prior to ART in Women With Endometriosis

In: Obstetrical & Gynecological Survey · 2022 · vol. 77(1) , pp. 32–33 · doi:10.1097/ogx.0000000000001002 · W4226104970
article OA: closed CC0 ⤵ 1 in-corpus citation
View on OpenAlex View at publisher
AI-generated summary by claude@2026-06, 2026-06-28

This randomized controlled trial evaluated the effect of ultra-long gonadotropin-releasing hormone (GnRH) downregulation prior to assisted reproductive technology (ART) in women with endometriosis, aiming to clarify its impact on clinical pregnancy rates.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

(Abstracted from Hum Reprod 2021;36:2676–2686) Although the adverse effect of endometriosis on pregnancy rate is well established, the impact of endometriosis on pregnancy rate after treatment with assisted reproductive technology (ART) remains unclear. There is evidence that the use of prolonged pituitary downregulation before ART in women with any degree of endometriosis increases the odds of clinical pregnancy significantly (up to 4-fold); however, this evidence is limited by potential methodology and publication bias.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (1)

Cited by (1)

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK